FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns an oral drug delivery system including biliquid foam containing continuous hydrophilic phase 1 to 20 wt %, pharmaceutically acceptable oil 70 to 98 wt % producing discontinuous phase. A slightly water-soluble drug 0.1 to 20 wt % is dissolved or dispersed in said pharmaceutically acceptable oil. The drug delivery system also contains biliquid foam with included surface-active substance 0.5 to 10 wt % to produce stable biliquid foam with all the amounts specified in percentage of total composition.
EFFECT: drug delivery system ensures high bioavailability of slightly water-soluble oral drugs.
22 cl, 16 ex, 1 tbl
Authors
Dates
2009-04-27—Published
2004-07-30—Filed